GlassScriptPhysician profile
Kalyan C Latchamsetty
NPI 1699724138
$3,062.53
in general payments reported to CMS, 2019-2025
12 companies · $850 in 2025
The $850 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $217 · 2021: $142 · 2022: $181 · 2023: $177 · 2024: $152 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $850 · Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $850.00 |
| Food and Beverage | $329.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $900.00 | 2019 | |
| Olympus Winter & Ibe Gmbh | $850.00 | 2025 | Endoeye Flex Deflectable Videoscope |
| Boston Scientific Corporation | $489.63 | 2019-2024 | Lithovue, Spaceoar Vue System - 10ml |
| Olympus America INC. | $316.22 | 2019-2022 | |
| Astellas Pharma US INC | $178.24 | 2019-2020 | |
| Richard Wolf Medical Instruments Corp. | $145.85 | 2019 | |
| Abbvie INC. | $96.65 | 2019-2023 | |
| Palette Life Sciences, INC. | $33.13 | 2022 | |
| Rochester Medical Corporation | $19.14 | 2019 | |
| Ethicon US, LLC | $17.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$122,060.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalyan Latchamsetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.